News

Apranga Group Shows Strong Growth in Retail Turnover

Apranga Group Shows Strong Growth in Retail Turnover

Apranga Group Reports Impressive Interim Financial Results

In a remarkable achievement, Apranga Group has reported a retail turnover of EUR 251.4 million for the first nine months of 2024. This figure marks an impressive increase of 8.7% compared to the same period last year. Such growth signifies the company's strong positioning within the retail market, a reflection of effective strategies and dedicated customer engagement.

Profit Before Income Tax Reflects Strategic Management

The unaudited consolidated profit before income tax for Apranga Group reached EUR 15.2 million during the same period. Although this represents a slight decrease from the previous year's profit of EUR 15.8 million, it still indicates a solid performance amid challenging economic conditions. The Group's management attributes this stability to its robust operational framework and strategic planning.

EBITDA Growth Signals Positive Operations

In terms of operational efficiency, the Group's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) climbed to EUR 31.2 million in the first nine months of 2024. This is a modest increase of 0.5% from the prior year's performance. This growth in EBITDA showcases Apranga Group's continued ability to manage costs effectively while capitalizing on market opportunities.

Future Plans Indicate Strong Market Positioning

Looking ahead, Apranga Group has set ambitious goals for 2024, targeting a turnover of EUR 350 million, which would represent a 7% increase over the 2023 turnover. This confidence is bolstered by a revised investment forecast indicating that the company plans to renovate or open 18 new stores throughout the year. The expected net investment will be approximately EUR 8 million, marking a significant commitment to expanding its retail footprint.

Strategic Store Renovation and Openings

The planned renovations and new store openings are essential for maintaining a competitive edge in the dynamic retail environment. Apranga Group's strategy emphasizes enhancing customer experiences and adapting to changing consumer preferences by strategically selecting locations that drive foot traffic.

Commitment to Shareholders and Stakeholders

The management's communication about the interim financial statements demonstrates transparency and commitment to its stakeholders. Apranga Group prioritizes maintaining strong relationships with investors, ensuring they are kept informed about the company's operations and performance.

Management Insights and Contact Information

Rimantas Perveneckas, the General Manager of Apranga Group, expresses optimism for the future. The Group's commitment to adapting its business strategy in response to market shifts is evident in its proactive planning.

For more information or inquiries, interested parties can reach Rimantas Perveneckas directly at +370 5 2390801.

Frequently Asked Questions

What were Apranga Group's retail turnover results for 2024?

Apranga Group achieved a retail turnover of EUR 251.4 million in the first nine months of 2024, reflecting an 8.7% increase compared to the previous year.

How did the profit before income tax change?

The profit before income tax for the group was EUR 15.2 million, a slight decrease from EUR 15.8 million recorded in the same period of 2023.

What is the company's EBITDA performance?

Apranga Group's EBITDA reached EUR 31.2 million for the first nine months of 2024, which is a 0.5% increase from the previous year's results.

What are the Group's future plans for expansion?

In 2024, Apranga Group aims for a turnover of EUR 350 million and plans to renovate or open 18 new stores with an investment of about EUR 8 million.

Who can be contacted for more information about Apranga Group?

Rimantas Perveneckas, the General Manager, can be contacted at +370 5 2390801 for further inquiries about the company's operations and financial performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 8

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 5

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 6

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading

Top 5 Most Recently Viewed Articles

IDEX Biometrics Welcomes Kristian Flaten as New CFO

Updated Category News Views 117

Kristian Flaten Appointed as Chief Financial Officer at IDEX Biometrics IDEX Biometrics has made a significant addition to its executive team by appointing Kristian Flaten as Chief Financial Officer. Flaten’s expertise is expected to play a crucial role in steering the company through its pivotal growth stages. A Wealth of Experience in Financial Leadership With more...

Continue Reading
Innovative Dosing Insights for GLOPERBA® Unveiled in Study

Updated Category News Views 150

Exciting Developments in GLOPERBA® Dosing Adjustments In a recent milestone for pain management, Scilex Holding Company (Nasdaq: SCLX) has published findings on GLOPERBA® dosing adjustments in a peer-reviewed journal. GLOPERBA® stands out as the first liquid oral version of colchicine, a medication widely used for gout treatment. This innovative formulation is...

Continue Reading
Cheesecake Factory's Winning Quarter Sparks Investor Interest

Updated Category News Views 173

Cheesecake Factory Reports Impressive Quarterly Results The restaurant sector is buzzing with excitement as Cheesecake Factory Inc (NASDAQ: CAKE) recently disclosed noteworthy financial outcomes for its latest quarter. Investors are taking notice of the company's enhanced revenue and strategic growth initiatives. Quarterly Financial Overview In a significant development,...

Continue Reading
Latest Trading Disclosure from Dowlais Group plc Unveiled

Updated Category News Views 179

Overview of Public Trading Disclosure FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Key Highlights The recent disclosures outline the trading activities involving Dowlais Group plc and highlight the role of Investec Bank plc as the exempt principal trader. Providing...

Continue Reading
CROSSJECT's Strategic Advancement with ETON in Adrenal Care

Updated Category News Views 170

CROSSJECT's Growing Collaboration with ETON PHARMACEUTICALS CROSSJECT is excited to announce an enhancement in its partnership with ETON PHARMACEUTICALS, Inc. This collaboration revolves around the groundbreaking hydrocortisone formulation, aimed at entering the hospital adrenal insufficiency market. By working together, CROSSJECT has positioned itself to earn a...

Continue Reading